During the past decade, Multiprofile Hospital for Active Treatment Uni Hospital; Department of medicinal oncology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Multiprofile Hospital for Active Treatment Uni Hospital; Department of medicinal oncology" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Pfizer" with 2 trials sponsored, "BeiGene" with 1 trials sponsored, "Celcuity, Inc." with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Multiprofile Hospital for Active Treatment Uni Hospital; Department of medicinal oncology" #1 collaborator was "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Foundation Medicine, Inc." with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Multiprofile Hospital for Active Treatment Uni Hospital; Department of medicinal oncology" are "NSCLC" (2 trials), "Breast Cancer" (1 trials), "Cancer of Unknown Primary Site" (1 trials), "Cervical Cancer" (1 trials) and "Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Multiprofile Hospital for Active Treatment Uni Hospital; Department of medicinal oncology" in a lesser frequency.

Most popular intervention types in "Multiprofile Hospital for Active Treatment Uni Hospital; Department of medicinal oncology" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Alectinib" (2 trials), "Atezolizumab" (2 trials), "Bevacizumab" (2 trials), "5-FU" (1 trials) and "Alpelisib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Multiprofile Hospital for Active Treatment Uni Hospital; Department of medicinal oncology" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Multiprofile Hospital for Active Treatment Uni Hospital; Department of medicinal oncology". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Multiprofile Hospital for Active Treatment Uni Hospital; Department of medicinal oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Multiprofile Hospital for Active Treatment Uni Hospital; Department of medicinal oncology, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".